AI Vivo
PrivateLast Round
Grant
Mar 24, 2026
Total Funding Raised
$103,000
Company Overview
AI Vivo is a biotechnology company that develops an AI-based proprietary pharmacology platform designed to capture the dynamic effect of diseases and treatments at the organ level to accelerate drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AI Vivo Comparables
Compare AI Vivo with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VeriSIM Life | 87% | |
| Pathway Bio | 86% | |
| CytoReason | 86% |
AI Vivo Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 24, 2026 | ||||
| Accelerator | Nov 23, 2020 |
AI Vivo Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Amadeus Capital Partners | Seed |
| KQ Labs | Accelerator |
| Acequia Capital | Seed |
| o2h ventures | Seed |
| The Francis Crick Institute | Accelerator |
| LifeArc | Accelerator |
| Martlet Capital | Seed |
AI Vivo Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about AI Vivo's valuation, stock price, and market status.
Is AI Vivo a public or private company?
AI Vivo is a private company.
What is the current stock price of AI Vivo?
AI Vivo is a private company with no public stock price. No recent secondary market data is available.
How much is AI Vivo worth (valuation)?
Valuation information for AI Vivo is not publicly available.
Can I buy AI Vivo stock?
AI Vivo shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was AI Vivo's last funding round?
AI Vivo's most recent funding round was Accelerator on November 23, 2020.
Who are the main investors in AI Vivo?
Key investors in AI Vivo include KQ Labs, o2h ventures, The Francis Crick Institute, LifeArc, Martlet Capital.
Will AI Vivo IPO soon?
No public IPO plans have been announced for AI Vivo.
How can I track AI Vivo secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AI Vivo's secondary market activity and sign up for updates.